Predictors of successful outcome after adrenalectomy for primary aldosteronism
Open accessAbstract
The underlying cause of resistant hypertension after adrenalectomy for primary hyperaldosteronism remains controversial. The objective of this study was to identify preoperative factors predictive of resistant hypertension in patients after undergoing retroperitoneoscopic adrenalectomy. Between 2003 and 2009, 124 patients with unilateral aldosterone-producing adenoma or unilateral adrenal hyperplasia underwent retroperitoneoscopic adrenalectomy at our institution. Clinical and biochemical data were reviewed retrospectively at baseline and after a median follow-up time of 59.2 ± 37.2 months. Adrenalectomy cured hypertension in 68 patients (54.8%) and 43 (34.8%) had persistent hypertension that was much easier to control after surgery, whereas 13 patients (10.4%) had continued hypertension and poor blood pressure control. Multivariate regression analysis revealed that the main determinants of postoperative cure were duration of hypertension less than 5 years [odds ratio (OR): 6.515, 95% confidence interval (CI) 2.278-10.293), number of antihypertensive medications ≤2 (OR: 2.939, 95% CI 1.254-5.235), preoperative response to spironolactone (OR: 3.405, 95% CI 1.681-6.985), the TT genotype of the CYP11B2 gene (344 C/T) (OR: 2.765, 95% CI 1.221-4.986), and the presence of adenoma rather than hyperplasia (OR: 5.274, 95% CI 2.150-8.141). The main determinants of surgical cure or control of hypertension in patients with primary hyperaldosteronism were duration of hypertension, number of antihypertensive medications, preoperative response to spironolactone, the presence of adenoma, and CYP11B2 (344 C/T) genotype. Consideration of these factors may help in the evaluation of patients for surgery and for the identification of patients with continued postoperative hypertension that may require more long-term monitoring and treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Older patients and those with longstanding hypertension are more likely to have irreversible vascular damage and persistent hypertension requiring antihypertensive medication despite successful surgery.
“Older patients and those with longstanding hypertension are more likely to have irreversible vascular damage and have persistent hypertension requiring antihypertensive medication, despite successful surgery (335).”
From Adrenal incidentaloma (2020) · cites this paper as [335]
Cites
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541 · see citing works
Δούμα, Σ., Petidis, K., Doumas, M. N., Papaefthimiou, P., Triantafyllou, Α., Kartali, N., Papadopoulos, N., Vogiatzis, K., & Zamboulis, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60834-x · Cited by 559 · see citing works
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372 · see citing works
Rossi, G. P., Bolognesi, M., Rizzoni, D., Seccia, T. M., Piva, A., Porteri, E., Tiberio, G. A. M., Giulini, S. M., Agabiti‐Rosei, E., & Pessina, A. C. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.111369 · Cited by 232 · see citing works
Potentially high prevalence of primary aldosteronism in a primary-care population
Lim, P. O., Rodgers, P., Cardale, K., Watson, A., & MacDonald, T. M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74868-6 · Cited by 228 · see citing works
The Aldosteronoma Resolution Score
Zarnegar, R., Young, W. F., Lee, J. D., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318165c075 · Cited by 227 · see citing works
Factors Influencing Outcome of Surgery for Primary Aldosteronism
Çelen, O. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430180072015 · Cited by 180 · see citing works
Bassett, M., Zhang, Y., Clyne, C., White, P., & Rainey, W. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280125 · Cited by 146 · see citing works
Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism
Sywak, M. S., & Pasieka, J. L. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02261.x · Cited by 142 · see citing works
Proye, C. A. G., Mulliez, E., Carnaille, B. M. L., Lecomte-Houcke, M., Decoulx, M., Wemeau, J. L., Lefèbvre, J., Racadot, A., Ernst, O., Huglo, D. G., et al. (1998) · Surgery · doi:10.1067/msy.1998.93108 · Cited by 125 · see citing works
Fogari, R., Preti, P. S., Zoppi, A., Rinaldi, A., Fogari, E., & Mugellini, A. (2007) · Hypertension Research · doi:10.1291/hypres.30.111 · Cited by 121 · see citing works
Long‐term Follow‐up after Adrenalectomy for Primary Aldosteronism
Meyer, A. A., Brabant, G. E., & Behrend, M. (2005) · World Journal of Surgery · doi:10.1007/s00268-004-7496-z · Cited by 112 · see citing works
Walz, M. K., Gwosdz, R., Levin, S. L., et al. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9513-0 · Cited by 102 · see citing works
Adrenalectomy Improves Arterial Stiffness in Primary Aldosteronism
Štrauch, B., Petrák, O., Zelinka, T., et al. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.243 · Cited by 97 · see citing works
Aldosterone and Cardiovascular Disease
Gaddam, K. K., Pimenta, E., Husain, S., & Calhoun, D. A. (2009) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2008.10.002 · Cited by 69 · see citing works
Selective Use of Adrenal Venous Sampling in the Lateralization of Aldosterone‐producing Adenomas
Tan, Y. Y., Ogilvie, J. B., Triponez, F., Caron, N. R., Kebebew, E., Clark, O. H., & Duh, Q. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0622-8 · Cited by 66 · see citing works
Is Adrenal Venous Sampling Necessary in All Patients with Hyperaldosteronism before Adrenalectomy?
Zarnegar, R., Bloom, A., Lee, J. D., et al. (2008) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2007.08.022 · Cited by 64 · see citing works
Ye, P., Nakamura, Y., Lalli, E., & Rainey, W. E. (2009) · Endocrinology · doi:10.1210/en.2008-0667 · Cited by 52 · see citing works
Diagnosis and treatment of primary aldosteronism
Rossi, G. P. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9162-8 · Cited by 37 · see citing works
Diagnosis and Treatment of Primary Aldosteronism
Rossi, G. P. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.005 · Cited by 37 · see citing works
The Role of Adrenal Venous Sampling in the Surgical Management of Primary Aldosteronism
Toniato, A., Bernante, P., Rossi, G. P., et al. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0482-2 · Cited by 35 · see citing works
Zarnegar, R., Lee, J., Brunaud, L., et al. (2007) · Surgery · doi:10.1016/j.surg.2007.09.001 · Cited by 34 · see citing works
Renal damage in primary aldosteronism: Results of the PAPY study
Tuck, M. L., & Corry, D. B. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0016-4 · Cited by 34 · see citing works
Long-Term Results of Endoscopic Adrenalectomy for Conn's Syndrome
Gockel, I., Heintz, A., Polta, M., et al. (2007) · The American Surgeon · doi:10.1177/000313480707300218 · Cited by 29 · see citing works
Isaji, M., Mune, T., Takada, N., Yamamoto, Y., Suwa, T., Morita, H., Takeda, J., & White, P. C. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000170377.00591.7e · Cited by 29 · see citing works
Arlt, W. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0869 · Cited by 26 · see citing works
Fahey, T. J. (2009) · Yearbook of Surgery · doi:10.1016/s0090-3671(09)79429-7 · Cited by 23 · see citing works
Kim, R. M., Lee, J., & Soh, E.-Y. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.7.1041 · Cited by 19 · see citing works
Nejatizadeh, A., Kumar, R., Stobdan, T., Goyal, A. K., Gupta, M. D., Tyagi, S., Jain, S. K., & Pasha, M. A. Q. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.09.015 · Cited by 17 · see citing works
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 14 · see citing works
van Rijn-Bikker, P. C., Mairuhu, G., van Montfrans, G. A., Sijbrands, E. J. G., Zwinderman, A. H., Guchelaar, H., & Koopmans, R. P. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.192 · Cited by 12 · see citing works
Rossi, G. P., & Pessina, A. C. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283224393 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347 · see citing works
“Older patients and those with longstanding hypertension are more likely to have irreversible vascular damage and have persistent hypertension requiring antihypertensive medication, despite successful surgery (335).”
Background
- Authors
- Wang, W., Hu, W., Zhang, X., Wang, B., Bin, C., & Huang, H.
- Affiliations
- General Hospital of Guangzhou Military Command (CN)
- Department of Urology, Guangzhou General Hospital of Guangzhou Military Command (Guangzhou Liuhuaqiao Hospital), Guangzhou, Guangdong province, China
- Sun Yat-sen University (CN)
- Venue
- International Surgery
- Publisher
- International College of Surgeons
- Published
- 2012-10
- Volume
- 97
- Issue
- 2
- Pages
- 104-111
- ISSN
- 0020-8868 (ISSN-L)
- 2520-2456
- PMC
- PMC3723202
- OpenAlex
- W2076941575
- Cited by
- 43
- References
- 32
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 2 · 2013: 2
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- International Surgery (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, adrenalectomy, retroperitoneoscopic adrenalectomy, resistant hypertension, postoperative hypertension, aldosterone-producing adenoma, adrenal hyperplasia, duration of hypertension, antihypertensive medication use, predictors of surgical outcome
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adrenalectomy, Adult, Decision Support Techniques, Female, Follow-Up Studies, Genetic Markers, Humans, Hyperaldosteronism, Hypertension, Hypokalemia, Male, Middle Aged, Laparoscopy, Retrospective Studies, Multivariate Analysis, Logistic Models, Treatment Outcome, Cytochrome P-450 CYP11B2, Polymorphism, Single Nucleotide, Preoperative Period, Genotyping Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review